Key Consultants

Dr Miles Prince (Clinical Advisor)

• Clinical oncologist at the Peter MacCallum Cancer Centre, Head of Cancer Research at the Epworth Private Hospitals, Melbourne and a Professor at both Melbourne and Monash universities.
• Miles is engaged in major stem cell research and the mechanisms of the immune systems’ control of blood and cancer growth.

Professor Michael Brown

• Heads the Cancer Clinical Trials at Royal Adelaide Hospital where he is also a medical oncologist.
• Pioneer of phase 1 trial of CAR T cell therapy for metastatic melanoma.

Dr Peter Hudson (Scientific Advisor)

• Founder/ CSO of multiple life science companies, with a focus on antibody technologies.
• A scientific expert with extensive expertise in commercial development of protein-based therapeutics with over 100 published reports and over 20 patents submitted.

Dr Maureen Howard (Project Management Advisor)

• Project management specialist who recently guided the immune CD47 cancer project at the Stem Cell Institute, Stanford University into clinical trials.
• VP Research Androgen, Corixa, ChemoCentrix California, Director Immunology DNAX, visiting scientist NIAID at NIH.

Dr Leigh Dayton (Communications Advisor)  

• A multi-award-winning science writer and broadcaster, previously with The Australian, the ABC, the Sydney Morning Herald and New Scientist magazine.
• Her PhD (2018) examines the barriers to scientific innovation in Australia.
• Focuses on helping discoveries move from the laboratory to the marketplace.

David Kneen (Industrialisation Advisor)

• Specialist in the industrialisation of advanced biologics – Cell, Gene and Tissue therapies – from pre-clinical to commercial scale manufacturing.
• Has supported many of the world’s leading biotherapeutics multinationals, emerging novel therapeutics players, and pioneering technology start-ups; previously VP Cell Therapy at Invetech.